tiprankstipranks
Cytek Biosciences (CTKB)
NASDAQ:CTKB
US Market
CTKB
Cytek Biosciences
RESEARCH TOOLSreports

Cytek Biosciences (CTKB) Income Statement

Compare
104 Followers

Cytek Biosciences Income Statement

Last quarter (Q4 2025), Cytek Biosciences's total revenue was $62.14M, an increase of 8.12% from the same quarter last year. In Q4, Cytek Biosciences's net income was $-44.08M. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 201.49M$ 200.45M$ 193.01M$ 164.04M$ 127.95M
Gross Profit
$ 104.46M$ 111.11M$ 109.43M$ 100.97M$ 79.14M
Operating Expenses
$ 144.84M$ 131.63M$ 137.27M$ 102.78M$ 69.99M
Depreciation and Amortization
$ 11.97M$ 10.49M$ 9.23M$ 5.66M$ 1.24M
EBITDA
$ -17.39M$ -10.03M$ -4.41M$ 9.49M$ 8.92M
Operating Income
$ -40.38M$ -20.52M$ -27.84M$ -1.80M$ 9.16M
Other Income/Expenses
$ 10.54M$ 14.82M$ 12.14M$ 3.06M$ -3.22M
Pretax Income
$ -29.84M$ -5.70M$ -15.71M$ 1.26M$ 5.94M
Net Income
$ -66.54M$ -6.02M$ -12.15M$ 2.58M$ 3.00M
Per Share Metrics
Basic EPS
$ -0.52$ -0.05$ -0.09$ 0.02$ 0.03
Diluted EPS
$ -0.52$ -0.05$ -0.09$ 0.02$ 0.03
Weighted Average Shares Outstanding
 127.75M 130.61M 135.28M 134.51M 133.75M
Weighted Average Shares Outstanding (Diluted)
 127.75M 130.61M 135.28M 138.56M 133.75M
Currency in USD

Cytek Biosciences Earnings and Revenue History